New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alzamend Neuro, Inc. (ALZN) vs Niki BioSolutions, Inc. (NIKI)
- Alzamend Neuro, Inc. ALZN 1.02 −1.92%
- Niki BioSolutions, Inc. NIKI 1.68 +5.00%
Alzamend Neuro, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Niki BioSolutions, Inc. are of similar size ($5.0M and $4.9M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Alzamend Neuro, Inc. leads on 6 and Niki BioSolutions, Inc. on 4.
Valuation
Profitability
| Metric | ALZN | NIKI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (87.96%) | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (921.74%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.23%) | 0.00% | (51.58%) |
| Return on assets | (122.36%) | 0.00% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack